SCHEMBL22327444

SCHEMBL22327444

C=COCCc1cc2c(/N=C/N(C)C)ncnc2n1[C@H]1CC(O)[C@@H](CO[Si](c2ccccc2)(c2ccccc2)C(C)(C)C)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24971624 0.87 ADORA3 (0.33) —
SCHEMBL22598549 0.81 METTL3 (0.39) —
SCHEMBL26068422 0.81 METTL3 (0.39) —
SCHEMBL25754040 0.78 TYMP (0.43) —
SCHEMBL20810884 0.77 ADK (0.38) —
SCHEMBL2611648 0.77 ADK (0.38) —
SCHEMBL2611621 0.73 CA2 (0.36) —
SCHEMBL22598353 0.72 POLB (0.37) —
SCHEMBL12047328 0.70 CA2 (0.36) —
SCHEMBL22327354 0.70 CA2 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257414-A1 NUCLEOTIDE ANALOGUES FIRST-CITIZENS BANK & TRUST COMPANY 2023-08-17 — — US disclosed
US-10738072-B1 Nucleotide analogues Singular Genomics Systems, Inc. (US) 2020-08-11 — — US disclosed
Send feedback